Anti-cardiolipin antibody syndrome is characterised by the presence of autoaniibJdies directed against phospholipids. It is most commonly associated with systemic lupus erythematosus (SLE), although it may occur in any of the autoimmune connective tissue disorders. Patients with this syndrome have an increased incidence of both venous and arterial thrombosis. 1 We present a patient who had anti-cardiolipin antibody syndrome, associated with a limited form of scleroderma called CREST syndrome (calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly and telangiectasia) in whom right brachiocephaIic vein thrombosis resulted in failure of central venous cannulation.
CASE REPORT
A 28-year-old female had been diagnosed with CREST syndrome in 1986. She subsequently developed and became strongly positive for anti-cardiolipin antibodies. There had been recurrent episodes of digital ischaemia recussitating amputations, recurrent venous thrombosis and pulmonary emboli requiring long-term anticoagulation with warfarin. She was also being treated with prednisolone for her disease process and captopril and omeprazole for hypertension and peptic ulcer disease respectively. On this occasion she presented with osteomyelitis of her fifth metatarsal head and was admitted for a twoweek course of intravenous antibiotics. At the time of admission her International Normalised Ratio (lNR) was 1.0. There had previously been difficulties with intravenous access and for this reason her attending physicians requested that a central venous line be inserted.
An attempt was made to insert a central venous catheter (7 French, 3-lumen 20-cm catheter, Arrow Reading PA, Product number CS-15703-E) into the right subclavian vein using the Seldinger technique. Blood was easily aspirated from the kit's needle but the guidewire would not feed freely beyond several centimetres. Several attempts were made at feeding the wire before the procedure was abandoned.
A left subclavian vein central venous catheter was easily inserted. Although easy aspiration of blood via the three ports confirmed intravascular placement, a check chest X-ray showed the tip to be in an anomalous position, possibly a thyroid vein ( Figure 1 ). Three days later the patient complained of discomfort related to this line and pain on injection of antibiotics. At this stage blood could only be aspirated from the distal port of the triple-lumen catheter. After discussion with the patient and her physicians, it was decided to remove this catheter and insert an internal jugular line on the right-hand side. Again, there was difficulty advancing the guidewire and the catheter would not pass beyond the root of the neck. A check X-ray showed the tip of the catheter near the origin of her right brachiocephalic --- vein and a neck X-ray showed more clearly the position of the central venous catheter (Figure 2 ). At this time, with the patient's consent, it was decided to perform a venogram to determine the anatomical abnormality causing the obstruction. Twenty ml of intravenous contrast was injected under image-intensifier control. The portable films obtained showed reflux of contrast back into both the internal and external jugular veins, with a filling defect within the right brachiocephalic vein, with complete obstruction to flow. There was also filling of dilated collateral vessels in the subclavicular region and crossing the midline (Figure 3) . The radiologist confirmed that these appearances were consistent with thrombosis and occlusion of the brachiocephalic vein.
The catheter was removed and the patient's physicians informed. The patient declined any further attempts at intravenous access and was discharged home on oral antibiotics.
DISCUSSION
Anti-cardiolipin antibody syndrome is characterised by the presence of antiphospholipid antibody In patients who have an increased tendency to (i) recurrent thrombosis-venous and arterial; (ii) recurrent abortions; (iii) thrombocytopenia; (iv) neurological disease-which may be thrombotic or due to cross-activity of antibody with cerebral phospholipids. 2 This syndrome was originally described in a subset of patients with SLE. Most of the patients described in the literature either have SLE or a lupus-like syndrome. However, anticardiolipin antibody may occur in a number of auto-immune disorders including CREST syndrome (as with this patient) or Mixed Connective Tissue Disease (MCTD). I. ' The autoantibodies are directed against negatively charged phospholipids (anti phospholipid antibody). Anticardiolipin antibodies are one of the family of antibodies directed against phospholipids. The antibodies have been found in the IgG, IgM and IgA classes, with those of the IgG class having the strongest association with clinical disease. 2 Detection and measurement of these anti-cardiolipin antibodies is by ELISA methodology and the test results are reported semi-quantitatively, i.e., negative, low positive, Anaesthesia and Intensive Care, Vol. 22. ,'io. 2, April, 1994 moderate positive or strongly positive. This patient had IgG antibodies and was strongly positive.
In-vitro coagulation tests in these patients show prolongation of phospholipid-dependent coagulation tests. This manifests as increased APTT and Kaolin cephalin clotting times. However, in vivo there is a marked increase incidence of thrombosis. The thrombotic risk in these patients is unexplained. A recent study has shown that these patients have biochemical evidence of an ongoing prothrombotic state. 3 There have been a number of postulated mechanisms. These include unbalanced platelet activation and endothelial prostacyclin production, inhibition of the natural anticoagulant, activated protein C and its cofactor, protein S, plus interference with thrombomodulin action. Thus, platelet aggregation and thrombosis occur. This may result in thrombocytopenia.
Up to 40% of these patients with anti-cardiolipin antibody syndrome present have thrombosis, most commonly venous but also arterial." The site of venous thrombosis include recurrent deep venous thrombosis of lower limbs, renal, retinal veins, axillary and portal vein thrombosis, and a case of superior vena caval obstruction has been reported. ' This patient had had previous central venous access, the most recent occasion being six months previously via the left subclavian vein. Thrombosis is a recognised delayed complication of central venous cannulation. This risk is even greater in patients with anti-cardiolipin antibody syndrome who have an ongoing prothrombotic state. It is recommended that in patients who have had recurrent venous thrombosis the INR be maintained in the range 2.0-2.4 with warfarin to effectively reduce the risk of recurrence. I Although this patient exhibited no typical symptoms of venous obstruction (i.e., swelling of the neck or arm or venous distension) she was at significant risk of central vein thrombosis because of her medical condition, her history of previous central venous access and her subtherapeutic anticoagulation.
The venogram demonstrated thrombosis of at least the right brachiocephalic vein. Historically, venography has been the standard for imaging central veins. However, it is invasive and may cause endothelial damage, resulting in thrombosis in 3-4070 of patients. An alternative imaging technique is duplex venous imaging and this has been shown to be of value in assessment of patients with or requiring central venous access. (,-Attempting insertion of central venous lines in patients with thrombosed central veins may be timeconsuming and potentially dangerous. Preoperative or pre-procedure duplex venous imaging may save time and reduce the risk of complications and this should be considered in patients with anti-cardiolipin antibody syndrome, especially those with a history of thrombosis and/or previous central venous access.
